Shanghai Shen Lian Biomedical Corporation (688098.SS) SHH

Currency In CNY

AD

Valuation

Market Cap3.39B
Enterprise Value3.28B
P/E Ratio-123.96
PEG Ratio2.2
Price/Sales Ratio11.9
Price/Book Ratio2.22
Enterprise/Revenue11.86
Enterprise/EBITDA105.56

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.09
Operating Margin-0.12
AD

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.02

Income Statement

Revenue288.27M
Revenue/Share0.73
Gross Profit288.27M
EBITDA43.78M
Net Income-19.09M
Diluted EPS-0.05

Balance Sheet

Total Cash65.59M
Total Cash/Share0.17
Total Debt53.45M
Total Debt/Equity0.04
Current Ratio3.54
Book Value Per Share3.67

Price History

52-Week Change-30.49
52-Week High12.36
52-Week Low7.29
Moving Average 50 Days8.52
Moving Average 200 Days8.86

Statistics

Average Volume4.16M
Shares Outstanding410.64M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.01
Last Split FactorN/A
Last Split DateN/A
AD